Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The impact of new vaccine introduction on immunization and health systems: a review of the published literature.

Hyde TB, Dentz H, Wang SA, Burchett HE, Mounier-Jack S, Mantel CF; New Vaccine Introduction Impact Published Literature Working Group.

Vaccine. 2012 Oct 5;30(45):6347-58. doi: 10.1016/j.vaccine.2012.08.029. Epub 2012 Aug 29. Review.

2.

Costs of vaccine programs across 94 low- and middle-income countries.

Portnoy A, Ozawa S, Grewal S, Norman BA, Rajgopal J, Gorham KM, Haidari LA, Brown ST, Lee BY.

Vaccine. 2015 May 7;33 Suppl 1:A99-108. doi: 10.1016/j.vaccine.2014.12.037.

PMID:
25919184
3.

The impact of introducing new vaccines on the health system: case studies from six low- and middle-income countries.

Burchett HE, Mounier-Jack S, Torres-Rueda S, Griffiths UK, Ongolo-Zogo P, Rulisa S, Edengue JM, Chavez E, Kitaw Y, Molla M, Konate M, Gelmon L, Onyango-Ouma W, Lagarde M, Mills A.

Vaccine. 2014 Nov 12;32(48):6505-12.

4.

New vaccine introductions: assessing the impact and the opportunities for immunization and health systems strengthening.

Wang SA, Hyde TB, Mounier-Jack S, Brenzel L, Favin M, Gordon WS, Shearer JC, Mantel CF, Arora N, Durrheim D.

Vaccine. 2013 Apr 18;31 Suppl 2:B122-8. doi: 10.1016/j.vaccine.2012.10.116. Review.

5.

Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.

Jauregui B, Garcia AG, Bess Janusz C, Blau J, Munier A, Atherly D, Mvundura M, Hajjeh R, Lopman B, Clark AD, Baxter L, Hutubessy R, de Quadros C, Andrus JK.

Vaccine. 2015 May 7;33 Suppl 1:A28-33. doi: 10.1016/j.vaccine.2014.10.090.

6.

Status of New Vaccine Introduction - Worldwide, September 2016.

Loharikar A, Dumolard L, Chu S, Hyde T, Goodman T, Mantel C.

MMWR Morb Mortal Wkly Rep. 2016 Oct 21;65(41):1136-1140. doi: 10.15585/mmwr.mm6541a3.

7.

Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.

Blau J, Hoestlandt C, D Clark A, Baxter L, Felix Garcia AG, Mounaud B, Mosina L.

Vaccine. 2015 May 7;33 Suppl 1:A34-9. doi: 10.1016/j.vaccine.2014.12.073.

PMID:
25919171
8.

The impact of new vaccine introduction on the coverage of existing vaccines: a cross-national, multivariable analysis.

Shearer JC, Walker DG, Risko N, Levine OS.

Vaccine. 2012 Dec 14;30(52):7582-7. doi: 10.1016/j.vaccine.2012.10.036. Epub 2012 Oct 23.

PMID:
23099327
10.
11.

Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.

Teimouri F, Kebriaeezadeh A, Zahraei SM, Gheiratian M, Nikfar S.

Daru. 2017 Jan 14;25(1):1. doi: 10.1186/s40199-017-0166-0.

12.

Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.

Peny JM, Gleizes O, Covilard JP.

Vaccine. 2005 Aug 31;23(37):4610-8.

PMID:
15979769
13.

Global routine vaccination coverage, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Oct 29;59(42):1367-71.

14.

Sustainable introduction of affordable new vaccines: the targeting strategy.

Batson A.

Vaccine. 1998 Nov;16 Suppl:S93-8. Review.

PMID:
9915047
15.

Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.

Menzies R, Turnour C, Chiu C, McIntyre P.

Commun Dis Intell Q Rep. 2008 Jun;32 Suppl:S2-67. Review.

16.

Examining the cost of delivering routine immunization in Honduras.

Janusz CB, Castañeda-Orjuela C, Molina Aguilera IB, Felix Garcia AG, Mendoza L, Díaz IY, Resch SC.

Vaccine. 2015 May 7;33 Suppl 1:A53-9. doi: 10.1016/j.vaccine.2015.01.016.

PMID:
25919175
17.

Vaccination in Southeast Asia--reducing meningitis, sepsis and pneumonia with new and existing vaccines.

Richardson A, Morris DE, Clarke SC.

Vaccine. 2014 Jul 16;32(33):4119-23. doi: 10.1016/j.vaccine.2014.05.062. Epub 2014 Jun 5. Review.

PMID:
24907487
18.

ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.

Jauregui B, Janusz CB, Clark AD, Sinha A, Garcia AG, Resch S, Toscano CM, Sanderson C, Andrus JK.

Vaccine. 2015 May 7;33 Suppl 1:A21-7. doi: 10.1016/j.vaccine.2014.12.080.

PMID:
25919164
19.

The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.

Williams BA, Kidane T, Chirwa G, Tesfaye N, Prescott MR, Scotney ST, Valle M, Abebe S, Tambuli A, Malewezi B, Mohammed T, Kobayashi E, Wootton E, Wong R, Dosani R, Subramaniam H, Joseph J, Yavuz E, Apple A, Le Tallec Y, Kang'ethe A.

Health Policy Plan. 2016 Jun;31(5):563-72. doi: 10.1093/heapol/czv103. Epub 2016 Feb 7.

20.

A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization.

Ortiz JR, Perut M, Dumolard L, Wijesinghe PR, Jorgensen P, Ropero AM, Danovaro-Holliday MC, Heffelfinger JD, Tevi-Benissan C, Teleb NA, Lambach P, Hombach J.

Vaccine. 2016 Oct 26;34(45):5400-5405. doi: 10.1016/j.vaccine.2016.07.045. Epub 2016 Sep 16. Review.

Supplemental Content

Support Center